All Pathways
Emergency MedicineEmergency

Convulsive Status Epilepticus in Adults (AES 2016)

Convulsive Status Epilepticus in Adults (AES 2016): Convulsive status epilepticus in adults → Stabilise (0-5 min): airway, oxygen, monitoring, glucose →...

Pathway Overview

17 steps

Algorithm Steps

17 total

  1. 01Start

    Convulsive status epilepticus in adults

    Convulsive seizure lasting 5 min or more, or repeated seizures without recovery between them. Children: use the paediatric pathway. Neonates: not covered.

  2. 02Action

    Stabilise (0-5 min): airway, oxygen, monitoring, glucose

    Note the time the seizure started. Do not delay the benzodiazepine for tests.

    • Airway, oxygen by mask, recovery position, suction. Intubate if breathing is not adequate.
    • Monitor ECG, SpO2, BP and temperature.
    • IV access (IO if IV fails). Take blood for glucose, electrolytes, FBC, toxicology and antiseizure drug levels.
    • BGL below 4 mmol/L: thiamine 100 mg IV, then glucose 50% 50 mL IV (adult).
  3. 03Warning

    Pregnant 20 weeks or more, or up to 6 weeks after birth? Treat as eclampsia

    Magnesium sulfate is the first-line anticonvulsant in eclampsia. Call obstetrics and anaesthetics now. Prepare magnesium per the local obstetric protocol (high-alert medicine). Renal impairment or low urine output: risk of magnesium toxicity; check serum magnesium. Myasthenia gravis: magnesium can cause respiratory failure; get specialist advice.

    • Magnesium sulfate 4 g IV over 15 min, then 1 g/h IV for 24 h after the last seizure. Seizure again: further 2-4 g IV over 5-15 min.
    • Seizure still going: also give a benzodiazepine (next step). Do not use valproate.
    • BP 160/110 mmHg or more: treat urgently. On magnesium, watch reflexes, breathing and urine output.
  4. 04Action

    Benzodiazepine now (5-20 min): one full dose

    Adult doses (children: paediatric pathway; neonates: neonatal guideline). Give one full dose, not small split doses. Maximum 2 doses in total, including doses before hospital.

    • No IV access: midazolam IM 10 mg if over 40 kg (5 mg/mL: 2 mL); 5 mg if 13-40 kg (1 mL).
    • IV access: diazepam 0.15-0.2 mg/kg IV (max 10 mg per dose). May repeat once at 5-10 min.
    • Or lorazepam 0.1 mg/kg IV (max 4 mg per dose). May repeat once at 5-10 min.
    • Or midazolam 0.2 mg/kg buccal or intranasal (max 10 mg).
    • Watch breathing; have bag-mask ventilation ready. Prepare the second-line drug now.
  5. 05Action

    At the same time: find and treat the cause

    Do not delay anticonvulsants for tests or imaging.

    • Suspected CNS infection: start IV antibiotics and aciclovir now. No lumbar puncture while seizures continue.
    • Check Na, Ca, Mg, glucose, renal and liver function, blood gas, CK, drug levels and toxicology. Pregnancy test in women who could be pregnant.
    • Treat specific causes: severe hyponatraemia, hypocalcaemia, alcohol withdrawal, isoniazid overdose (pyridoxine).
    • Tricyclic or other sodium-channel-blocker overdose: sodium bicarbonate; avoid phenytoin. Poisons Information 13 11 26.
    • Missed antiseizure medicine is a common cause: restart the usual drugs.
    • CT head when stable. Consider MRI and EEG.
    • Dissociative (non-epileptic) seizures can look like status epilepticus. If in doubt, treat as status epilepticus.
  6. 06Decision

    Seizure stopped after the benzodiazepine?

    Reassess 5-10 min after each dose. Still seizing after the first dose (including IM or buccal midazolam): give one more benzodiazepine dose, IV if access. Still seizing after 2 doses: go to second-line.

  7. If Yes
    1. 07Outcome

      Seizure stopped: observe and treat the cause

      Not back to baseline, or subtle twitching: suspect non-convulsive status and get an urgent EEG. Restart usual antiseizure medicine.

    If No
    1. 08Action

      Second-line (20-40 min): ONE IV drug, full dose

      Continuous ECG and BP monitoring. Start as soon as 2 benzodiazepine doses have failed.

      • Levetiracetam 60 mg/kg IV (max 4500 mg) over 10 min. Quick to give; few adverse effects.
      • Or phenytoin 20 mg/kg IV (max 1500 mg) at max 50 mg/min (25 mg/min if elderly or heart disease). Give undiluted into a large vein; flush with 0.9% sodium chloride; do not mix with glucose. Not in bradycardia, SA or AV block, or tricyclic overdose. Already on phenytoin: choose another drug.
      • Or fosphenytoin 20 mg PE/kg IV (max 1500 mg PE) at max 150 mg PE/min, where available (not on the ARTG). Same cautions as phenytoin.
      • Or valproate 40 mg/kg IV (max 3000 mg) over 10 min. Not in pregnancy, liver disease, POLG mitochondrial or urea-cycle disorder, or with a carbapenem. Women who could become pregnant: prefer levetiracetam.
      • None of these available: phenobarbital 15 mg/kg IV (adult; total max 2 g), diluted 1 in 10, at max 60 mg/min. Not in porphyria. Expect hypotension and apnoea.
    2. 09Decision

      Seizure stopped after the second-line drug?

      Reassess at the end of the infusion. With expert advice, a different second-line drug can be tried while ICU is on the way.

    3. If Yes
      1. 10Action

        Seizure stopped: admit, monitor, start maintenance

        Not back to baseline: suspect non-convulsive status and get an EEG.

        • Admit to a monitored bed; ICU if intubated or not waking.
        • EEG if not back to baseline, or if intubated.
        • Start maintenance antiseizure medicine; check drug levels where useful.
        • Treat the cause. Agree an emergency management plan before discharge.
      2. 11Outcome

        Status epilepticus controlled

        Continue maintenance antiseizure medicine and treatment of the cause.

      If No
      1. 12Warning

        Refractory status epilepticus: call ICU and anaesthetics now

        Seizures continue after a benzodiazepine and a second-line drug.

        • Intubate and ventilate for an anaesthetic infusion; start continuous EEG. Neuromuscular blockers hide convulsions: use a short-acting agent; then only EEG shows seizures.
        • Expect hypotension: give fluids and a vasopressor as needed.
        • Continue maintenance antiseizure medicine at full dose.
      2. 13Action

        Third-line (from 40 min): anaesthetic infusion with continuous EEG

        Adult doses, in ICU. Titrate to stop seizures on EEG or to burst suppression.

        • Midazolam 0.2 mg/kg IV bolus (intubated adult), then 0.05-2 mg/kg/h infusion.
        • Or propofol 1-2 mg/kg IV bolus, then 30-200 microgram/kg/min. Above 4 mg/kg/h or beyond 48 h: risk of propofol infusion syndrome; check lactate, CK, K+ and triglycerides.
        • Or thiopental (thiopentone) or pentobarbital: dose per ICU protocol. Pentobarbital is not on the ARTG.
        • Keep seizure-free for 24-48 h, then wean slowly under EEG.
      3. 14Decision

        Seizures controlled on EEG?

        Assess on continuous EEG, including during weaning.

      4. If Yes
        1. 15Outcome

          Controlled: wean after 24-48 h seizure-free

          Wean the anaesthetic slowly under EEG. Continue maintenance antiseizure medicine and treat the cause.

        If No
        1. 16Warning

          Super-refractory: seizures 24 h or more after starting anaesthesia

          Includes seizures that return on weaning. Get tertiary epilepsy and ICU advice.

          • Look again for the cause, including autoimmune or infective encephalitis; consider immunotherapy with neurology.
          • Specialist options include ketamine, another anaesthetic agent or a ketogenic diet.
          • On propofol: check for propofol infusion syndrome.
        2. 17Outcome

          Tertiary specialist care

          High risk of death and disability. Discuss goals of care with the family.

Guideline Source

Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Adult doses only. Children: use the paediatric status epilepticus pathway. Neonates are outside the AES 2016 guideline.
  • Australia: fosphenytoin and pentobarbital are not on the ARTG; use phenytoin and thiopental. Midazolam injection is 5 mg/mL or 1 mg/mL.
  • Non-convulsive status epilepticus needs EEG to diagnose and is not covered in detail.
  • Third-line anaesthetic doses are specialist ICU doses; follow the local ICU protocol.
  • Evidence for second-line and third-line choices is limited (AES Level U/B); ESETT found levetiracetam, fosphenytoin and valproate similar.

Contraindicated Populations

neonateschildren (use the paediatric status epilepticus pathway)

Applicable Regions

AUUSEUInternational

AU: Fosphenytoin and pentobarbital are not on the ARTG (special access only); use phenytoin 20 mg/kg and thiopental. Lorazepam 2 mg/mL and 4 mg/mL injections are on the ARTG. Midazolam injection is 5 mg/mL or 1 mg/mL.

UK: NICE NG217: IV lorazepam first in hospital (buccal midazolam in the community); levetiracetam, phenytoin or valproate second-line, levetiracetam may be quicker with fewer adverse effects.

US: Fosphenytoin and IV lorazepam are widely available; IM midazolam is common before hospital.

International: Phenobarbital may be the only option in resource-limited settings.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Convulsive Status Epilepticus in Adults (AES 2016)?

The Convulsive Status Epilepticus in Adults (AES 2016) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

What guideline is the Convulsive Status Epilepticus in Adults (AES 2016) based on?

This algorithm is based on Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society (DOI: 10.5698/1535-7597-16.1.48).

What are the limitations of the Convulsive Status Epilepticus in Adults (AES 2016)?

Known limitations include: Adult doses only. Children: use the paediatric status epilepticus pathway. Neonates are outside the AES 2016 guideline.; Australia: fosphenytoin and pentobarbital are not on the ARTG; use phenytoin and thiopental. Midazolam injection is 5 mg/mL or 1 mg/mL.; Non-convulsive status epilepticus needs EEG to diagnose and is not covered in detail.; Third-line anaesthetic doses are specialist ICU doses; follow the local ICU protocol.; Evidence for second-line and third-line choices is limited (AES Level U/B); ESETT found levetiracetam, fosphenytoin and valproate similar.. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Convulsive Status Epilepticus in Adults (AES 2016) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free